BR112021017993A2 - Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos - Google Patents
Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacosInfo
- Publication number
- BR112021017993A2 BR112021017993A2 BR112021017993A BR112021017993A BR112021017993A2 BR 112021017993 A2 BR112021017993 A2 BR 112021017993A2 BR 112021017993 A BR112021017993 A BR 112021017993A BR 112021017993 A BR112021017993 A BR 112021017993A BR 112021017993 A2 BR112021017993 A2 BR 112021017993A2
- Authority
- BR
- Brazil
- Prior art keywords
- capsule
- methods
- lumen
- therapeutic agent
- drug delivery
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 7
- 238000002360 preparation method Methods 0.000 title abstract 7
- 229940124597 therapeutic agent Drugs 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title abstract 3
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000012377 drug delivery Methods 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 abstract 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962818053P | 2019-03-13 | 2019-03-13 | |
| US201962820174P | 2019-03-18 | 2019-03-18 | |
| PCT/US2020/022496 WO2020186121A1 (en) | 2019-03-13 | 2020-03-12 | Therapeutic agent preparations and methods for drug delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021017993A2 true BR112021017993A2 (pt) | 2022-01-18 |
Family
ID=72424820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021017993A BR112021017993A2 (pt) | 2019-03-13 | 2020-03-12 | Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200289620A1 (enExample) |
| EP (1) | EP3937971A4 (enExample) |
| JP (1) | JP2022524446A (enExample) |
| KR (1) | KR20210138646A (enExample) |
| CN (1) | CN113784724A (enExample) |
| AU (1) | AU2020237517A1 (enExample) |
| BR (1) | BR112021017993A2 (enExample) |
| CA (1) | CA3133086A1 (enExample) |
| MX (1) | MX2021011047A (enExample) |
| WO (1) | WO2020186121A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8721620B2 (en) | 2009-12-24 | 2014-05-13 | Rani Therapeutics, Llc | Swallowable drug delivery device and methods of drug delivery |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| AU2018366110B2 (en) * | 2017-11-07 | 2024-08-08 | Rani Therapeutics, Llc | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
| CN112451500B (zh) * | 2020-12-18 | 2022-05-17 | 南京鼓楼医院 | 一种磁响应载药微针机器人及其制备方法和应用 |
| WO2025081168A1 (en) * | 2023-10-12 | 2025-04-17 | The Brigham And Women's Hospital, Inc. | An intra-abdominal injection system |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8721620B2 (en) * | 2009-12-24 | 2014-05-13 | Rani Therapeutics, Llc | Swallowable drug delivery device and methods of drug delivery |
| US8809269B2 (en) * | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) * | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402807B2 (en) * | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8980822B2 (en) * | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) * | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9284367B2 (en) * | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8969293B2 (en) * | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) * | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9149617B2 (en) * | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9283179B2 (en) * | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10639272B2 (en) * | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9629799B2 (en) * | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9861683B2 (en) * | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) * | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US20230374155A1 (en) * | 2014-05-15 | 2023-11-23 | Rani Therapeutics, Llc | Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) * | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US11548940B2 (en) * | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| AU2015258859B2 (en) * | 2014-05-15 | 2020-07-23 | Rani Therapeutics, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| CN107847446A (zh) * | 2015-05-01 | 2018-03-27 | 因库博实验室有限责任公司 | 药物组合物和用于制备包含多肽和/或蛋白质的固体块的方法 |
| CA2993215C (en) * | 2015-07-02 | 2023-10-31 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| AU2018366110B2 (en) * | 2017-11-07 | 2024-08-08 | Rani Therapeutics, Llc | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
| US11473339B2 (en) * | 2018-01-31 | 2022-10-18 | Spectrum Brands, Inc. | Field-handable gate latch |
| CN113543756B (zh) * | 2018-12-31 | 2023-09-05 | 拉尼医疗有限公司 | 使用可吞服药物递送装置递送到肠道内腔的治疗剂制剂 |
| CA3137539A1 (en) * | 2019-05-03 | 2020-10-20 | Rani Therapeutics, Llc | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device |
-
2020
- 2020-03-12 BR BR112021017993A patent/BR112021017993A2/pt unknown
- 2020-03-12 CN CN202080028733.XA patent/CN113784724A/zh active Pending
- 2020-03-12 KR KR1020217032196A patent/KR20210138646A/ko not_active Abandoned
- 2020-03-12 CA CA3133086A patent/CA3133086A1/en active Pending
- 2020-03-12 EP EP20770263.0A patent/EP3937971A4/en not_active Withdrawn
- 2020-03-12 JP JP2021554738A patent/JP2022524446A/ja active Pending
- 2020-03-12 US US16/817,490 patent/US20200289620A1/en not_active Abandoned
- 2020-03-12 AU AU2020237517A patent/AU2020237517A1/en not_active Abandoned
- 2020-03-12 WO PCT/US2020/022496 patent/WO2020186121A1/en not_active Ceased
- 2020-03-12 MX MX2021011047A patent/MX2021011047A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN113784724A (zh) | 2021-12-10 |
| AU2020237517A1 (en) | 2021-10-14 |
| US20200289620A1 (en) | 2020-09-17 |
| AU2020237517A2 (en) | 2021-11-04 |
| EP3937971A1 (en) | 2022-01-19 |
| KR20210138646A (ko) | 2021-11-19 |
| EP3937971A4 (en) | 2022-12-14 |
| MX2021011047A (es) | 2021-12-15 |
| CA3133086A1 (en) | 2020-09-17 |
| JP2022524446A (ja) | 2022-05-02 |
| WO2020186121A1 (en) | 2020-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021017993A2 (pt) | Preparações de agente terapêutico e métodos para liberação de fármacos em um lúmen do trato intestinal com o uso de um dispositivo ingerível de liberação de fármacos | |
| MX2024005949A (es) | Preparaciones de agente terapeutico para administracion en un lumen del tracto intestinal utilizando un dispositivo de administracion de farmaco tragable. | |
| BR112021021904A2 (pt) | Preparações de fator da coagulação para liberação em tecido do trato intestinal usando um dispositivo de liberação de fármacos ingerível | |
| BR112021017289A2 (pt) | Distribuição propulsiva de fármacos a partir de um dispositivo engolível dentro do trato intestinal de um paciente | |
| WO2011112229A3 (en) | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device | |
| MX2022009523A (es) | Formulaciones farmaceuticas. | |
| WO2016172396A3 (en) | Multi-chamber sequential delivery syringe | |
| IN2014CN00338A (enExample) | ||
| BRPI0607549A2 (pt) | sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos | |
| MX2021012050A (es) | Formulaciones de proteinas liquidas que contienen agentes reductores de viscosidad. | |
| WO2007109684A3 (en) | Dose packaging system for load-dose titration administration of a liquid formulation | |
| EA201270795A1 (ru) | Комплект трубок с вентилем улучшенной конструкции для подключения флаконов | |
| BR112012019549A2 (pt) | reservatório para uso em um módulo medicamentoso, módulo medicamentoso que compreende esse reservatório e dispositivo de entrega de fármaco. | |
| BR112015022067A2 (pt) | método e aparato para a administração de droga a um sítio alvo | |
| BR112012033077B8 (pt) | Composição farmacêutica para administração intravenosa, uso de uma composição farmacêutica, e, kit | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| BR112014012522A2 (pt) | método para encher um reservatório, reservatório e conjunto para encher um reservatório | |
| MX378264B (es) | Sistema para la entrega de polímeros líquidos para la administración prolongada de fármacos. | |
| CY1113881T1 (el) | Ιατρικη συσκευη τοπικης χορηγησης φαρμακευτικων ουσιων | |
| BR112016027435A2 (pt) | formulação inovadora de meloxicam | |
| Binson et al. | Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps | |
| Dupoiron et al. | In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps | |
| WO2016100949A3 (en) | Method and compositions for dissolving or solubilizing therapeutic agents | |
| BR112022003895A2 (pt) | Sistema e método de entrega de múltiplos fármacos | |
| EP4473987A4 (en) | Device for administering a medicinal solution |